BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

516 related articles for article (PubMed ID: 31442290)

  • 1. Idiopathic pulmonary fibrosis in small cell lung cancer as a predictive factor for poor clinical outcome and risk of its exacerbation.
    Koyama N; Iwai Y; Nagai Y; Aoshiba K; Nakamura H
    PLoS One; 2019; 14(8):e0221718. PubMed ID: 31442290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of clinical courses and mortality of connective tissue disease-associated interstitial pneumonias and chronic fibrosing idiopathic interstitial pneumonias.
    Yıldırım F; Türk M; Bitik B; Erbaş G; Köktürk N; Haznedaroğlu Ş; Türktaş H
    Kaohsiung J Med Sci; 2019 Jun; 35(6):365-372. PubMed ID: 30913371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical features of patients with small cell lung cancer and idiopathic pulmonary fibrosis treated with chemotherapy or chemoradiotherapy.
    Kanaji N; Shimizu J; Sakai K; Ueda Y; Miyawaki H; Watanabe N; Uemura T; Hida T; Inoue T; Watanabe N; Oohara Y; Dobashi H; Kato M; Kadowaki N
    Ther Adv Respir Dis; 2020; 14():1753466620963866. PubMed ID: 33086985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of preexisting interstitial lung disease in Japanese patients with small-cell lung cancer.
    Togashi Y; Masago K; Handa T; Tanizawa K; Okuda C; Sakamori Y; Nagai H; Kim YH; Mishima M
    Clin Lung Cancer; 2012 Jul; 13(4):304-11. PubMed ID: 22169479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of incidence and outcome of acute exacerbation in idiopathic interstitial pneumonia.
    Arai T; Kagawa T; Sasaki Y; Sugawara R; Sugimoto C; Tachibana K; Kitaichi M; Akira M; Hayashi S; Inoue Y
    Respirology; 2016 Nov; 21(8):1431-1437. PubMed ID: 27460223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The feasibility study of Carboplatin plus Etoposide for advanced small cell lung cancer with idiopathic interstitial pneumonias.
    Minegishi Y; Kuribayashi H; Kitamura K; Mizutani H; Kosaihira S; Okano T; Seike M; Azuma A; Yoshimura A; Kudoh S; Gemma A
    J Thorac Oncol; 2011 Apr; 6(4):801-7. PubMed ID: 21336181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival and acute exacerbation for patients with idiopathic pulmonary fibrosis (IPF) or non-IPF idiopathic interstitial pneumonias: 5-year follow-up analysis of a prospective multi-institutional patient registry.
    Tsubouchi K; Hamada N; Tokunaga S; Ichiki K; Takata S; Ishii H; Kitasato Y; Okamoto M; Kawakami S; Yatera K; Kawasaki M; Fujita M; Yoshida M; Maeyama T; Harada T; Wataya H; Torii R; Komori M; Mizuta Y; Tobino K; Harada E; Yabuuchi H; Nakanishi Y; Okamoto I
    BMJ Open Respir Res; 2023 Nov; 10(1):. PubMed ID: 37963676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pulmonary Resection for Lung Cancer in Patients With Idiopathic Interstitial Pneumonia.
    Omori T; Tajiri M; Baba T; Ogura T; Iwasawa T; Okudela K; Takemura T; Oba MS; Maehara T; Nakayama H; Tsuboi M; Masuda M
    Ann Thorac Surg; 2015 Sep; 100(3):954-60. PubMed ID: 26116477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Implication of Proteinase-3-antineutrophil Cytoplasmic Antibody in Patients with Idiopathic Interstitial Pneumonias.
    Hozumi H; Enomoto N; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Lung; 2016 Apr; 194(2):235-42. PubMed ID: 26873743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment and outcome of lung cancer in idiopathic interstitial pneumonias.
    Kreuter M; Ehlers-Tenenbaum S; Schaaf M; Oltmanns U; Palmowski K; Hoffmann H; Schnabel PA; Heußel CP; Puderbach M; Herth FJ; Warth A
    Sarcoidosis Vasc Diffuse Lung Dis; 2015 Jan; 31(4):266-74. PubMed ID: 25591137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of respiratory virus detection in patients with acute exacerbation of interstitial lung diseases.
    Saraya T; Kimura H; Kurai D; Tamura M; Ogawa Y; Mikura S; Sada M; Oda M; Watanabe T; Ohkuma K; Inoue M; Honda K; Watanabe M; Yokoyama T; Fujiwara M; Ishii H; Takizawa H
    Respir Med; 2018 Mar; 136():88-92. PubMed ID: 29501253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of idiopathic pulmonary fibrosis on advanced non-small cell lung cancer survival.
    Kanaji N; Tadokoro A; Kita N; Murota M; Ishii T; Takagi T; Watanabe N; Tojo Y; Harada S; Hasui Y; Kadowaki N; Bandoh S
    J Cancer Res Clin Oncol; 2016 Aug; 142(8):1855-65. PubMed ID: 27350261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glasgow prognostic score for prediction of chemotherapy-triggered acute exacerbation interstitial lung disease in patients with small cell lung cancer.
    Kikuchi R; Takoi H; Tsuji T; Nagatomo Y; Tanaka A; Kinoshita H; Ono M; Ishiwari M; Toriyama K; Kono Y; Togashi Y; Yamaguchi K; Yoshimura A; Abe S
    Thorac Cancer; 2021 Jun; 12(11):1681-1689. PubMed ID: 33939332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy in idiopathic pulmonary fibrosis and small-cell lung cancer with poor lung function.
    Zhang X; Li W; Li C; Zhang J; Su Z
    BMC Pulm Med; 2021 Apr; 21(1):122. PubMed ID: 33858421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral-type small cell lung cancer is associated with better survival and higher frequency of interstitial lung disease.
    Kanaji N; Sakai K; Ueda Y; Miyawaki H; Ishii T; Watanabe N; Kita N; Kadota K; Kadowaki N; Bandoh S
    Lung Cancer; 2017 Jun; 108():126-133. PubMed ID: 28625624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of patients with chronic idiopathic interstitial pneumonia undergoing repeated respiratory-related hospitalizations: A retrospective cohort study.
    Yamazaki R; Nishiyama O; Saeki S; Sano H; Iwanaga T; Tohda Y
    PLoS One; 2020; 15(4):e0232212. PubMed ID: 32330195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy versus best supportive care in advanced lung cancer and idiopathic interstitial pneumonias: A retrospective multi-centre cohort study.
    Miyamoto A; Michimae H; Nakahara Y; Akagawa S; Nakagawa K; Minegishi Y; Ogura T; Hontsu S; Date H; Takahashi K; Homma S; Kishi K;
    Respir Investig; 2023 Mar; 61(2):284-295. PubMed ID: 36496345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis after acute exacerbation in patients with interstitial lung disease other than idiopathic pulmonary fibrosis.
    Miyashita K; Kono M; Saito G; Koyanagi Y; Tsutsumi A; Kobayashi T; Miki Y; Hashimoto D; Nakamura Y; Suda T; Nakamura H
    Clin Respir J; 2021 Mar; 15(3):336-344. PubMed ID: 33197284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of acute exacerbation of interstitial pneumonia after pulmonary resection for lung cancer in patients with idiopathic pulmonary fibrosis based on preoperative high-resolution computed tomography.
    Suzuki H; Sekine Y; Yoshida S; Suzuki M; Shibuya K; Yonemori Y; Hiroshima K; Nakatani Y; Mizuno S; Takiguchi Y; Yoshino I
    Surg Today; 2011 Jul; 41(7):914-21. PubMed ID: 21748606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis and nonspecific interstitial pneumonia: a nonrandomized prospective study.
    Abe M; Tsushima K; Matsumura T; Ishiwata T; Ichimura Y; Ikari J; Terada J; Tada Y; Sakao S; Tanabe N; Tatsumi K
    Drug Des Devel Ther; 2015; 9():5755-62. PubMed ID: 26566367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.